Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.23
+0.1%
$0.26
$0.19
$2.98
$7.15M1.1913.21 million shs7.09 million shs
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
C$1.78
+∞
C$1.78
C$0.12
C$3.55
C$27.51MN/A2.39 million shs1.13 million shs
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
C$36.70
-0.3%
C$36.49
C$33.89
C$38.96
C$1.42T0.617924125,985 shs26,048 shs
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
$19.81
+0.2%
$19.63
$16.84
$20.20
$788.04M0.59268,517 shs111,329 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-0.38%-6.52%-11.14%-54.69%-90.49%
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
0.00%0.00%0.00%0.00%0.00%
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
+0.52%+0.74%-1.81%+3.63%-0.92%
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
-0.90%-0.40%+0.15%+4.16%+11.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.23
+0.1%
$0.26
$0.19
$2.98
$7.15M1.1913.21 million shs7.09 million shs
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
C$1.78
+∞
C$1.78
C$0.12
C$3.55
C$27.51MN/A2.39 million shs1.13 million shs
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
C$36.70
-0.3%
C$36.49
C$33.89
C$38.96
C$1.42T0.617924125,985 shs26,048 shs
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
$19.81
+0.2%
$19.63
$16.84
$20.20
$788.04M0.59268,517 shs111,329 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-0.38%-6.52%-11.14%-54.69%-90.49%
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
0.00%0.00%0.00%0.00%0.00%
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
+0.52%+0.74%-1.81%+3.63%-0.92%
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
-0.90%-0.40%+0.15%+4.16%+11.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
3.00
Buy$9.003,746.15% Upside
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
0.00
N/AN/AN/A
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
0.00
N/AN/AN/A
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
2.39
Hold$19.79-0.09% Downside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$90K79.14N/AN/A$0.25 per share0.94
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
N/AN/AN/AN/AN/AN/A
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
C$438.31B3.25N/AN/AN/A
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$13.96M-$24.68N/AN/AN/A-15,021.05%N/A-143.02%N/A
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
N/AC$2.1916.73N/AN/AN/AN/AN/AN/A
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
N/AN/A11.57N/AN/AN/AN/AN/AN/A

Latest BRK, DIV, AIM, and BLOC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A-$0.43N/A-$0.43N/A$0.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
N/AN/AN/AN/AN/A
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
N/AN/AN/AN/AN/A
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
$1.266.36%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A
2.11
2.11
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
N/AN/AN/A
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
N/AN/AN/A
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2030.44 million30.15 millionNot Optionable
Global Blockchain Technologies Corp. stock logo
BLOC
Global Blockchain Technologies
147,00015.46 millionN/ANot Optionable
Berkshire Hathaway Inc. stock logo
BRK
Berkshire Hathaway
N/A38.81 billionN/ANot Optionable
Global X SuperDividend U.S. ETF stock logo
DIV
Global X SuperDividend U.S. ETF
N/A39.79 millionN/ANot Optionable

Recent News About These Companies

Guide to High Dividend-Paying ETFs
Global X SuperDividend™ U.S. ETF
DIV: Stability Meets Quality Dividend Distributions
Time for Quality & Value ETFs?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSEAMERICAN:AIM

$0.23 0.00 (-0.73%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Global Blockchain Technologies stock logo

Global Blockchain Technologies CVE:BLOC

C$1.78 +1.78 (+∞)
As of 01/19/2018

Global Blockchain Technologies Corp., a tier 2 investment company, focuses on identification and investment in a diversified portfolio of public and private companies in China. The company was formerly known as Carrus Capital Corporation and changed its name to Global Blockchain Technologies Corp. in October 2017. Global Blockchain Technologies Corp. was incorporated in 2010 and is based in Vancouver, Canada.

Berkshire Hathaway stock logo

Berkshire Hathaway TSE:BRK

C$36.70 -0.10 (-0.27%)
As of 11:46 AM Eastern

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from these and its other operations over the years to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the firms that make up its manufacturing, service, and retailing operations (which include five of Berkshire's largest noninsurance pretax earnings generators: Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis.

Global X SuperDividend U.S. ETF stock logo

Global X SuperDividend U.S. ETF NYSEARCA:DIV

$19.80 +0.04 (+0.18%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Global X SuperDividend U.S. ETF (DIV) is an exchange-traded fund that mostly invests in high dividend yield equity. The fund tracks an equally weighted index of 50 high-dividend, low-volatility securities. DIV was launched on Mar 11, 2013 and is managed by Global X.